Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study
about
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisThe macrophages in rheumatic diseasesImmature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy.Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabNew insights in synovial angiogenesis.Angiogenesis in rheumatoid arthritis.Angiogenesis and its targeting in rheumatoid arthritisTargeting Angiogenesis in Rheumatoid ArthritisHalting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumabCause for controversy? Infliximab in the treatment of ulcerative colitis: an update.Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatmentSynovial Tissue Response to Treatment with TNF Blockers in Peripheral SpondyloarthritisAngiogenesis blockade as a new therapeutic approach to experimental colitis.Immunobiologics in the treatment of psoriasis.A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissueCombination systemic therapies in psoriatic arthritis.Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.Investigational VEGF antagonists for psoriasis.Putative effects of potentially anti-angiogenic drugs in rheumatic diseases.The potential role of angiogenic factors in rheumatoid arthritis.Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis.Synovial tissue response to treatment in psoriatic arthritis.Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms.Macrophages and angiogenesis in rheumatic diseases.Heparin Attenuates the Expression of TNFalpha-induced Cerebral Endothelial Cell Adhesion Molecule.Study of in vitro capillary-like structures in psoriatic skin substitutes.Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function.Association analysis of BANK1 gene with psoriasis in Southern Han Chinese.Very late antigen-1 in psoriasis: an immunohistochemical study.Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.Light and electron microscopic features of synovium in patients with psoriatic arthritis.Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.Distinguishing rheumatoid arthritis from psoriatic arthritisNotch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis
P2860
Q22305863-07B471F3-5D68-4E3D-B804-C0DC5A6A017FQ26765275-D1EF158A-71AC-4398-8B45-F0E83D402812Q30941105-FC0B6B66-BD5F-4CD7-9B49-2953D9A2729EQ33390403-79D0271D-777B-4B68-9EEF-E6A1CA05AA84Q33573621-60692822-C9DF-4E22-B9CC-664F686D638AQ34022062-5DB06B48-4C08-45C7-80B8-1F90F15CA07DQ34051829-C54A289C-9713-4E5E-8164-865FBE7676C7Q34051950-3560EC2F-7C70-4A32-9160-0B8DA2037EB7Q34058895-F557E9DF-2964-49BF-99E2-98279DCD2CE4Q34428875-67CC8858-EB99-4E60-BDDB-BDCFEABA77D7Q34906120-3E5DC2F6-5F6A-44ED-844D-C90D7ABAD49EQ35026302-CDEF4703-A515-48EF-8CD9-4A58C3602985Q35638455-17FC6DD9-B6F8-4908-8A8C-7DAE8B3A4A57Q35687019-FBF0B894-C07A-4263-AB1A-70655F37F39CQ35953816-F5297A5B-5745-4E35-8E25-964DCDBDC4E2Q36743142-F5A274D5-82D1-42F2-BB41-F3A247BB60A7Q37245184-81765AAC-6F12-458E-96EE-55C08D02E21BQ37776265-515C481B-E16B-46F5-BF0F-AEDF1CA1AB35Q37810960-C4F31353-DE2E-4A5D-9B56-94E4CF6E3E1EQ37866683-CC659F63-4548-49EE-9D97-7D75C93C0AB6Q37956733-A3687257-6A17-44B8-8346-A23927B18A27Q38160325-7703EE2F-E4CF-4267-A966-4F61AF54D4C9Q38182175-31B5DBE7-7ACB-4680-B2A3-C061F50E7636Q38239111-B328731E-78E6-4FF4-B82E-5B7F144A06AEQ38582187-0829C8F2-8D99-4874-AAB1-6546A43C0053Q38841195-A3856395-FB05-497E-A390-356E4F641F56Q38969036-F24E73DA-7C86-4426-8B6E-E92926A7F7E5Q40576433-9A576A20-475A-4943-8C8F-99A051116C32Q41208827-1E193EB6-105D-424F-B815-A6C663666A10Q41849684-257BE81E-68EC-40F1-8F29-71CC7326BFB9Q41887059-DA8B14A2-1823-4366-91DB-BD9ED07CC710Q42039509-99CEB9A3-A7B5-4FBC-9536-541C95F20556Q42104777-3817C297-D472-4BF4-8DF7-B446B2010967Q44295692-8E082EDD-EDE5-4453-A32F-F989DD484967Q46758055-2EB4D556-17FF-4B43-9325-A75DF0E08A35Q49586531-7F8307E3-045F-4269-BDBB-1B28FB82ACB3Q53153872-FB92A049-F184-40F5-B200-51AA8CCC201FQ54592971-41307AAC-9CAE-499A-9C91-457C174E2EF6Q58785143-C9453074-14D7-4CFF-B72A-3C54BABDB2D2Q59041872-CC210799-CCF9-459E-A0F4-5115EFB14E15
P2860
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Deactivation of endothelium an ...... rospective single-centre study
@ast
Deactivation of endothelium an ...... rospective single-centre study
@en
Deactivation of endothelium an ...... rospective single-centre study
@en-gb
Deactivation of endothelium an ...... rospective single-centre study
@nl
type
label
Deactivation of endothelium an ...... rospective single-centre study
@ast
Deactivation of endothelium an ...... rospective single-centre study
@en
Deactivation of endothelium an ...... rospective single-centre study
@en-gb
Deactivation of endothelium an ...... rospective single-centre study
@nl
prefLabel
Deactivation of endothelium an ...... rospective single-centre study
@ast
Deactivation of endothelium an ...... rospective single-centre study
@en
Deactivation of endothelium an ...... rospective single-centre study
@en-gb
Deactivation of endothelium an ...... rospective single-centre study
@nl
P2093
P2860
P3181
P356
P1476
Deactivation of endothelium an ...... rospective single-centre study
@en
P2093
Amber Y Goedkoop
Daisy I Picavet
Maarten C Kraan
Marcel B M Teunissen
Menno A de Rie
Paul P Tak
P2860
P2888
P304
P3181
P356
10.1186/AR1182
P407
P577
2004-01-01T00:00:00Z